Morbid obesity, regardless of the degree of insulin resistance, was associated with changes in the expression of genes involved in pro- (such as CD86 and S100A8) and anti-inflammatory (such as CCL18 and ZBTB16) responses (Figure 4). The gene discussed is ZBTB16; the disease is Insulin resistance.